We demonstrated that serum γ-GGT was a promising and reliable prognostic biomarker in HCC patients after hepatic resection, especially for patients with small HCC or AFP ≤ 200 ng/mL21. This evidence concerns the gene AFP and hepatocellular carcinoma.